Paper Details

  1. Home
  2. Paper Details

A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.

Author: BeyP, BourdinS, ClaverieN, HahneW, Le FlochO, ResbeutM, WilkinsonP M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Dolasetron mesilate was effective and well-tolerated in the control of single, high-dose radiotherapy-induced emesis.
Paper Details　
Original Abstract of the Article :
The aim of this work was to measure the safety and efficacy of single i.v. doses of dolasetron mesilate for the control of emesis caused by single high-dose (at least 6 Gy) radiotherapy to the upper abdomen. The double-blind, placebo-controlled, multicenter study stratified patients on the basis of ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF01788845

データ提供：米国国立医学図書館（NLM）

Dolasetron Mesilate: A Shield Against Radiotherapy-Induced Nausea and Vomiting

Radiotherapy, a powerful weapon in the fight against cancer, can often leave patients feeling like they are traversing a desert of discomfort. This study investigates the potential of dolasetron mesilate, a medication that can help to alleviate the nausea and vomiting associated with radiotherapy. The researchers conducted a rigorous double-blind, placebo-controlled trial, like scientists carefully testing a new drug, to determine the effectiveness of dolasetron mesilate.

This study is like a compass, guiding us through the challenging landscape of radiotherapy side effects. The researchers demonstrate the effectiveness of dolasetron mesilate in controlling radiotherapy-induced nausea and vomiting, offering a potential solution for patients facing this difficult side effect.

Dolasetron Mesilate: A Boon for Radiotherapy Patients

The results of this study are like a refreshing oasis in the desert of radiotherapy side effects. They show that dolasetron mesilate is effective in preventing nausea and vomiting, offering a significant improvement in quality of life for patients undergoing radiotherapy.

Navigating Radiotherapy: A Guide for You

The findings of this study highlight the importance of discussing potential side effects with your doctor before starting radiotherapy. Dolasetron mesilate, a medication that can effectively manage nausea and vomiting, may be an important part of your treatment plan.

Dr.Camel's Conclusion

This study provides valuable insights into the potential of dolasetron mesilate to alleviate the debilitating side effects of radiotherapy. It offers a glimmer of hope for patients navigating the challenging journey of cancer treatment. By understanding the effectiveness of this medication, we can better equip patients to manage the discomfort associated with radiotherapy and focus on their recovery.

Date :
  1. Date Completed 1997-02-04
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

8883232

DOI: Digital Object Identifier

10.1007/BF01788845

Related Literature

Article Analysis
・Effects of dolasetron injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.